The impact of prescription charges on asthma patients is uneven and unpredictable: Evidence from qualitative interviews

Primary Care Respiratory Journal

Volumn 18, Issue 4, 2009, Pages 266-272

  Schafheutle, Ellen I ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Adherence; Asthma; Cost; Management; Qualitative; Treatment

Indexed keywords

ANTIBIOTIC AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; LISINOPRIL; SALBUTAMOL; STEROID;

ADULT; ARTICLE; ASTHMA; DISEASE CONTROL; DRUG COST; FEMALE; HEALTH INSURANCE; HUMAN; INHALER; INTERVIEW; MALE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRESCRIPTION; QUALITY OF LIFE;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DECISION MAKING; DRUG COSTS; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT COMPLIANCE; PRIMARY HEALTH CARE;

EID: 72149116680     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2009.00012     Document Type: Article

References (37)

1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: an executive summary of the GINA Dissemination Committee Report. Allergy 2004;59:469-478 http://dx.doi.org/10.1111/j.1398-9995.2004.00526.x (Pubitemid 38580764)
2. Asthma UK. Where do we stand? Asthma in the UK today. Asthma UK, London; 2004. http://www.asthma.org.uk/document.rm?id=92 (accessed 8 October 2008).
3. British Thoracic Society and Scottish Intercollegiate Guidelines Network. British Guideline on the Management of Asthma. A National Clinical Guideline (No 101). London & Edinburgh: BTS & SIGN, 2008.
4. National Heart, Lung and Blood Institute and National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. U.S. Department of Health and Human Services, 28-8-2007.
5. Elliott RA. Poor adherence to anti-inflammatory medication in asthma. Reasons, challenges, and strategies for improved disease management. Disease Management & Health Outcomes 2006;14:223-233 http://dx.doi.org/10.2165/ 00115677-200614040-00005
6. De Smet BD, Erickson SR, Kirking DM. Self-reported adherence in patients with asthma. Ann Pharmacother 2006;40:414-420 http://dx.doi.org/10.1345/aph. 1G475
7. Cerveri I, Locatelli F, Zoia MC, Corsico A, Accordini S, de Marco R. International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS). Eur Respir J 1999;14:288-294 http://dx.doi.org/10.1034/j.1399-3003.1999.14b09.x (Pubitemid 29461291)
8. Williams LK, Pladevall M, Xi H, et al. Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma. J Allergy Clin Immunol 2004;114:1288-1293 http://dx.doi.org/10.1016/j.jaci.2004.09.028 (Pubitemid 39575880)
9. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-336 http://dx.doi.org/10.1056/NEJM200008033430504 (Pubitemid 30616699)
10. Bender BG, Bender SE. Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires. Immunol Allergy Clin N Am 2005;25:107-130 http://dx.doi.org/10.1016/j.iac.2004.09.005
11. Halm EA, Mora P, Leventhal H. No symptoms, no asthma: the acute episodic disease belief Is associated with poor self-management among inner-city adults with persistent asthma. Chest 2006;129:573-580 http://dx.doi.org/10.1378/ chest.129.3.573
12. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 2001;285:421-429 http://dx.doi.org/10.1001/jama.285.4.421 (Pubitemid 32097260)
13. Lexchin J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004;34:101-122 (Pubitemid 38393061)
14. Dormuth CR, Glynn RJ, Neumann P, Maclure M, Brookhart AM, Schneeweiss S. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma. Clin Ther 2006;28:964-978 http://dx.doi.org/10.1016/j.clinthera.2006.06. 007 (Pubitemid 44062695)
15. Blais L, Couture J, Rahme E, LeLorier J. Impact of a cost sharing drug insurance plan on drug utilization among individuals receiving social assistance. Health Policy 2002;64:163-72. http://dx.doi.org/10.1016/S0168- 8510(02)00158-166
16. Kozyrskyj AL, Mustard CA, Cheang MS, Simons FER. Income-based drug benefit policy: Impact on receipt of inhaled corticosteroid prescriptions by Manitoba children with asthma. Can Med Assoc J 2001;165:897-902.
17. Information Centre. Prescriptions Dispensed in the Community. Statistics for 1997 to 2007: England. London: The Information Centre (Health Care), 10-7-2008.
18. NHS. HC 11 - Help with Health Costs. London: Department of Health, 2005.
19. Information Centre. Prescriptions Dispensed in the Community. Statistics for 1996 to 2006: England. London: The Information Centre (Health Care), 27-7-2007.
20. Schafheutle EI, Hassell K, Noyce PR. Coping with prescription charges in the UK. Int J Pharm Pract 2004;12:239-246 http://dx.doi.org/10.1211/ 0022357044995
21. Schafheutle EI, Hassell K, Seston EM, Noyce PR. Non-dispensing of NHS prescriptions in community pharmacies. Int J Pharm Pract 2002;10:11-15. (Pubitemid 34298437)
22. Schafheutle EI, Hassell K, Noyce PR, Weiss MC. Access to medicines: cost as an influence on the views and behaviour of patients. Health Soc Care Community 2002;10:187-195 http://dx.doi.org/10.1046/j.1365-2524.2002.00356.x (Pubitemid 36844273)
23. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In Bryman, A. Analyzing Qualitative Data, 173-194. London and New York: Routledge, 1994.
24. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ 2000;320:114-116 http://dx.doi.org/10.1136/bmj. 320.7227.114
25. Schafheutle EI. Patients' views on the UK policy of prescription charges - Insights from qualitative interviews. Res Social Adm Pharm 2008;4:343-354
26. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA 2004;292:952-960 http://dx.doi.org/10.1001/ jama.292.8.952 (Pubitemid 39097205)
27. Cox ER, Henderson RR. Prescription use behaviour among Medicare beneficiaries with capped prescription benefits. J Manag Care Pharm 2002;8:360-364
28. Cox ER, Jernigan C, Joel Coons SJ, Draugalis JR. Medicare beneficiaries' management of capped prescription benefits. Med Care 2001;39:296-301. http://dx.doi.org/10.1097/00005650-200103000-00009 (Pubitemid 33694140)
29. Strickland WJ, Hanson CM. Coping with the cost of prescription drugs. J Health Care Poor Underserved 1996;7:50-62.
30. Barnett R. Coping with the costs of primary care? Household and locational variations in the survival strategies of the urban poor. Health & Place 2001;7:141-57. http://dx.doi.org/10.1016/S1353-8292(01)00013-22
31. Heisler M, Wagner TH, Piette JD. Patient strategies to cope with high prescription medication costs: Who is cutting back on necessities, increasing debt, or underusing medications? J Behav Med 2005;28:43-51. http://dx.doi.org/ 10.1007/ s10865-005-2562-z (Pubitemid 40543870)
32. Weiss MC, Hassell K, Schafheutle EI, Noyce PR. Strategies used by General Practitioners to minimise the impact of the prescription charge. Eur J Gen Pract 2001;7:23-26 (Pubitemid 32215414)
33. Adams S, Pill R, Jones A. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med 1997;45:189-201. http://dx.doi.org/10.1016/S0277-9536(96)00333-334
34. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47:555-67. http://dx.doi.org/10.1016/S0022-3999(99)00057-64
35. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining nonadherence to preventer medication. Psychology and Health 2002;17:17-32.
36. Phelps L. Unhealthy Charges. CAB Evidence on the Impact of Health Charges. London: National Association of Citizens Advice Bureaux, 2001.
37. Government Response to the Health Committee's Report on NHS Charges. Presented to Parliament by the Secretary of State for Health by Command of Her Majesty. London: Crown Copyright, 2006.